These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 11149892)
1. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. Jones SA; Horiuchi S; Topley N; Yamamoto N; Fuller GM FASEB J; 2001 Jan; 15(1):43-58. PubMed ID: 11149892 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. Rose-John S; Scheller J; Elson G; Jones SA J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558 [TBL] [Abstract][Full Text] [Related]
3. Major role of the soluble interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines. Gaillard JP; Liautard J; Klein B; Brochier J Eur J Immunol; 1997 Dec; 27(12):3332-40. PubMed ID: 9464821 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor. Peake NJ; Khawaja K; Myers A; Nowell MA; Jones SA; Rowan AD; Cawston TE; Foster HE Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760 [TBL] [Abstract][Full Text] [Related]
5. Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms. McLoughlin RM; Hurst SM; Nowell MA; Harris DA; Horiuchi S; Morgan LW; Wilkinson TS; Yamamoto N; Topley N; Jones SA J Immunol; 2004 May; 172(9):5676-83. PubMed ID: 15100312 [TBL] [Abstract][Full Text] [Related]
6. The soluble IL-6 receptors: serum levels and biological function. Montero-Julian FA Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):583-97. PubMed ID: 11502067 [TBL] [Abstract][Full Text] [Related]
7. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Atreya R; Mudter J; Finotto S; Müllberg J; Jostock T; Wirtz S; Schütz M; Bartsch B; Holtmann M; Becker C; Strand D; Czaja J; Schlaak JF; Lehr HA; Autschbach F; Schürmann G; Nishimoto N; Yoshizaki K; Ito H; Kishimoto T; Galle PR; Rose-John S; Neurath MF Nat Med; 2000 May; 6(5):583-8. PubMed ID: 10802717 [TBL] [Abstract][Full Text] [Related]
8. Myeloma cells release soluble interleukin-6Ralpha in relation to disease progression by two distinct mechanisms: alternative splicing and proteolytic cleavage. Thabard W; Barillé S; Collette M; Harousseau JL; Rapp MJ; Bataille R; Amiot M Clin Cancer Res; 1999 Oct; 5(10):2693-7. PubMed ID: 10537331 [TBL] [Abstract][Full Text] [Related]
9. The soluble Interleukin 6 receptor: generation and role in inflammation and cancer. Chalaris A; Garbers C; Rabe B; Rose-John S; Scheller J Eur J Cell Biol; 2011; 90(6-7):484-94. PubMed ID: 21145125 [TBL] [Abstract][Full Text] [Related]
10. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125 [TBL] [Abstract][Full Text] [Related]
11. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases. Michalopoulou M; Nikolaou C; Tavernarakis A; Alexandri NM; Rentzos M; Chatzipanagiotou S; Cambouri C; Vassilopoulos D Immunol Lett; 2004 Jul; 94(3):183-9. PubMed ID: 15275965 [TBL] [Abstract][Full Text] [Related]
12. IL-6 transsignaling: the in vivo consequences. Jones SA; Richards PJ; Scheller J; Rose-John S J Interferon Cytokine Res; 2005 May; 25(5):241-53. PubMed ID: 15871661 [TBL] [Abstract][Full Text] [Related]
13. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Mihara M; Hashizume M; Yoshida H; Suzuki M; Shiina M Clin Sci (Lond); 2012 Feb; 122(4):143-59. PubMed ID: 22029668 [TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes. Gabay C; Silacci P; Genin B; Mentha G; Le Coultre C; Guerne PA Eur J Immunol; 1995 Aug; 25(8):2378-83. PubMed ID: 7545121 [TBL] [Abstract][Full Text] [Related]
15. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression. Oh JW; Van Wagoner NJ; Rose-John S; Benveniste EN J Immunol; 1998 Nov; 161(9):4992-9. PubMed ID: 9794436 [TBL] [Abstract][Full Text] [Related]
16. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors. Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033 [TBL] [Abstract][Full Text] [Related]
17. Soluble IL-6R alpha upregulated IL-6, MMP-1 and MMP-2 secretion in bone marrow stromal cells. Barillé S; Collette M; Thabard W; Bleunven C; Bataille R; Amiot M Cytokine; 2000 Sep; 12(9):1426-9. PubMed ID: 10976008 [TBL] [Abstract][Full Text] [Related]
18. IL-6 and IL-1 synergistically enhanced the production of MMPs from synovial cells by up-regulating IL-6 production and IL-1 receptor I expression. Suzuki M; Hashizume M; Yoshida H; Shiina M; Mihara M Cytokine; 2010 Aug; 51(2):178-83. PubMed ID: 20403707 [TBL] [Abstract][Full Text] [Related]
19. Human myeloma cells promote the recruitment of osteoblast precursors: mediation by interleukin-6 and soluble interleukin-6 receptor. Karadag A; Scutt AM; Croucher PI J Bone Miner Res; 2000 Oct; 15(10):1935-43. PubMed ID: 11028445 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 receptor signaling. II. Bio-availability of interleukin-6 in serum. Gaillard J; Pugnière M; Tresca J; Mani J; Klein B; Brochier J Eur Cytokine Netw; 1999 Sep; 10(3):337-44. PubMed ID: 10477390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]